Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 1,565 | 1,263 | 1,491 |
| Gross Profit | N/A | N/A | 1,565 | 1,263 | 1,491 |
| Operating Expenses | 114,398 | 100,047 | 86,143 | 82,471 | 66,091 |
| Operating Income | -114,398 | -100,047 | -84,578 | -81,208 | -64,600 |
| Interest Expense | 9,277 | 6,599 | 6,200 | 4,348 | 2,202 |
| Other Income | -25,026 | -4,130 | 78,813 | 59,079 | 278 |
| Pre-tax Income | -148,701 | -110,776 | -11,965 | -26,477 | -66,524 |
| Net Income Continuous | -148,701 | -110,776 | -11,965 | -26,477 | -66,524 |
| Net Income | $-148,701 | $-110,776 | $-11,965 | $-26,477 | $-66,524 |
| EPS Basic Total Ops | -1.26 | -1.07 | -0.12 | -0.66 | -11.54 |
| EPS Basic Continuous Ops | -1.26 | -1.07 | -0.12 | -0.66 | -11.54 |
| EPS Diluted Total Ops | -1.26 | -1.07 | -0.12 | -0.66 | -11.54 |
| EPS Diluted Continuous Ops | -1.26 | -1.07 | -0.12 | -0.66 | -11.54 |
| EPS Diluted Before Non-Recurring Items | -1.05 | -0.93 | -0.86 | -2.06 | N/A |
| EBITDA(a) | $-107,208 | $-91,846 | $-74,822 | $-71,990 | $-56,249 |